CDK4 and neoplasm: Specifically, CDK4/6 inhibition potently attenuates the proliferation of T regulatory cells (Tregs), relieving immunosuppression in the tumor microenvironment, and has also been shown to enhance activation of effector T cells through the depression of nuclear factor of activated T cells (NFAT) transcription factors9,10,16,18.